Company intelligence / Profile preview

Evolution Optiks

Christ Church, Barbadosevolutionoptiks.com ↗

Ownership: Private
Employees: ~14
Development stage: Commercial

Overview

Evolution Optiks has received FDA 510(k) clearance and CE Mark for its LFR–260 light field-powered tele-refractor. Clinical studies have demonstrated safety and efficacy of their DeCon device for vestibular disorder diagnostics. The company is preparing commercial launch of its flagship products in the US and Europe[4][6][8].

Therapeutic areas: OphthalmologyNeurology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

John McEnroe Tennis Academy – partnership to develop neuro fitness training wearableMotoAmerica – collaboration on concussion diagnostics in motorsports

Beyond the preview

Go deeper on Evolution Optiks.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evolution Optiks.